TECHBio-Techne

Health care · Biotechnology · Nasdaq

Headquarters: Minneapolis, MN
CEO: Kim Kelderman
Next results: around Feb 3, 2027

RevenueFY2017–26 $1.2B−0.4% FY2025: $1.2B 10-K FY2026 · XBRL Net incomeFY2017–26 $181.8M+147.7% FY2025: $73.4M 10-K FY2026 · XBRL Free cash flowFY2017–26 $263.2M+2.6% FY2025: $256.6M 10-K FY2026 · XBRL Operating marginFY2017–26 20.7%+12.3 pts 21.4% in FY2017 10-K FY2026 · XBRL

What changed

10-K filed Aug 24, 2026 against Aug 22, 2025

Area	What changed	Source
Risk factors	31 new paragraphs, nothing like them in the previous 10-K	10-K Item 1A
Accounting checks	11 other checks clear	10-K · XBRL
Insiders	No open-market buys in the last 90 days	Form 4
Filings	3 in the last 30 days	EDGAR

Each row opens the detail with the quote and the filing. A row is a change worth reading, not a verdict.

What's new, in their words

10-K filed Aug 24, 2026

Paragraphs in Risk Factors that were not in the 10-K filed 2025-08-22. Quoted as filed.

For instance, our use of animal-derived materials in certain products and manufacturing processes subjects us to regulatory, supply chain, quality, and reputational risks that could adversely affect our business. The sourcing, processing, importation, exportation, handling, storage, transportation and use of animal-derived materials are…
10-K, Item 1A

All 31 new paragraphs →

Accounting checks

latest 10-K

11 of 11 clear 0 worth a look. Checks, not verdicts.

✓
Receivables +4.7% vs revenue -0.4% (+5.1 pts)
✓
Cash from operations $292.1M vs net income $181.9M (FY ending 2026-06-30)
✓
Inventory +3.3% vs revenue -0.4% (+3.7 pts)
✓
Same auditor in both 10-Ks: KPMG LLP
✓
No statement of substantial doubt about going concern
✓
No 8-K item 4.02 in the last 2 years
✓
No NT 10-K or NT 10-Q in the last 2 years
✓
The same matters as last year: Sufficiency of audit evidence over net sales
✓
No sentence in the 10-K concludes that controls were not effective because of a material weakness
✓
No 8-K item 2.06 in the last 2 years
✓
No 8-K item 1.03 in the last 2 years

How each check works, with sources →

In the last 30 days

All filings →

Nov 6, 202610-Q Quarterly report (10-Q) period ended Sep 30, 2026
Nov 4, 20268-K Other events 8-K item 8.01
Oct 28, 202610-K Annual report (10-K) (amended) period ended Jun 30, 2026

Get an email when this changes: new risk paragraphs, accounting items, insider purchases, a new 10-K or 10-Q. RSS feed

Work on TECH in a spreadsheet: Excel workbook (a sheet per section, ten years by column, charts, links to the filings) · CSV. For a Google Sheet that stays up to date, paste =IMPORTDATA("https://tickdelta.com/company/TECH/export.csv") into a cell.